000002.SZ
000002.SZ
CNE0000000T2
VANKE-A
Loading chart...
Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 45/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score
7/7 Very High
7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Moves noticeably less than the broader market (0.6x).

Beta (Market Relation)
0.64x
Defensive
Volatility (5Y p.a.)
38.4% p.a.
5-Year Horizon
Max Drawdown (5Y)
-86.8%
5-Year Horizon
Sharpe Ratio
-0.81
Return / Risk
Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

High Volatility
Timeframe
Volatility (p.a.)
Max Drawdown
Sharpe Ratio
Return (p.a.)
1 Year — — — -40.2%
3 Years 39.3% -77.0% -0.87 -31.8%
5 Years 38.4% -86.8% -0.81 -28.2%
10 Years 37.2% -92.8% -0.52 -16.9%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Unprofitable business model: The company is currently generating net losses.
Strong cyclicality: The business model is sensitive to economic downturns.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (38.4% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -92.8% in the extended horizon.
ende